Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits
NCT ID: NCT04328207
Last Updated: 2025-08-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
900 participants
INTERVENTIONAL
2020-11-18
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glaucoma Management Optimism for African Americans Living With Glaucoma
NCT03159481
Improving African American Glaucoma Patient Involvement in Visits and Outcomes
NCT03657147
Determinants of Compliance With Glaucoma Therapy
NCT00362622
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
NCT02390245
Community Based Treatment for (ComBaT) Glaucoma
NCT06124521
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No financial incentive
This group will receive standard of care eye health education alone and no financial incentive for completing a referral visit.
No Financial Incentive
Standard of care eye health education
Financial incentive
This group will receive a financial incentive once the referral visit is completed (if one was required) as well as eye health education.
Financial Incentive
Patients who are referred for an in-person follow-up exam will receive a financial incentive once the referral visit is completed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Financial Incentive
Standard of care eye health education
Financial Incentive
Patients who are referred for an in-person follow-up exam will receive a financial incentive once the referral visit is completed.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-Hispanic white ≥50 years
* Anyone ≥ 18 years with diabetes
* Anyone ≥ 18 years with a glaucoma associated diagnosis
* Anyone ≥ 18 years with a family history of glaucoma
* All enrollees must be able to speak and understand English
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centers for Disease Control and Prevention
FED
University of Alabama at Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cynthia Owsley
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher A Girkin, MD, MSPH
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama at Birmingham
Birmingham, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rhodes LA, Register S, Asif I, McGwin G Jr, Saaddine J, Nghiem VTH, Owsley C, Girkin CA. Alabama Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (AL-SIGHT): Study Design and Methodology. J Glaucoma. 2021 May 1;30(5):371-379. doi: 10.1097/IJG.0000000000001794.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Website describing the research program as well as two other research programs funded by the same mechanism.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1U01DP006441-01-00
Identifier Type: OTHER
Identifier Source: secondary_id
IRB-300004921
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.